G1 Therapeutics News

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Jacks

Jun 14 16:47 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flowers Cynthia Louise

Jun 14 16:47 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Secor Alicia

Jun 14 16:46 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sharpless Norman

Jun 14 16:46 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MUIR GLENN P

Jun 14 16:45 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicholson Garry A

Jun 14 16:40 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thomas Monica R.

May 24 16:19 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perry Andrew

May 15 22:24 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MURDOCK TERRY L

May 15 22:24 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bailey John E. (Jack) Jr.

May 15 17:14 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Malik Rajesh

May 15 17:01 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

May 15 16:21 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Avagliano Mark

May 15 16:18 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Avagliano Mark

Mar 22 16:14 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thomas Monica R.

Mar 22 16:13 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

Mar 22 16:13 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

Mar 20 16:33 ET

G1 Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fredric N. Eshelman(9.26%),Eshelman Ventures, LLC(8.13%)

Feb 21 16:37 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Malik Rajesh

Feb 13 18:17 ET

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

Jan 8 00:00 ET